FoxP3 in Peripheral Blood Is Associated With Operational Tolerance in Liver Transplant Patients During Immunosuppression Withdrawal
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Human liver allografts do sometimes survive in a recipient after withdrawal of immunosuppression (IS), commonly referred to as "operational tolerance." Preliminary clinical data have suggested an increase in the frequency of regulatory T cells (Treg) CD4+CD25 high and FoxP3 expression in operationally tolerant liver transplant recipients (Gr-T). In the context of human liver transplantation, the dynamics of Treg have not been studied. We designed a prospective study to ascertain the profile of the Treg population and FoxP3 expression during IS withdrawal. METHODS: To identify such parameters, we analyzed peripheral blood mononuclear cell populations and FoxP3 mRNA expression in 12 liver allograft recipients under cyclosporine A-based IS, who showed stable function of the allograft for more than 2 years. RESULTS: An increase was observed in the frequency of CD4+CD25 high cells when the IS was withdrawn in Gr-T patients (n=5). These patients exhibited a 3.5-fold increase for relative mRNA FoxP3 expression before the complete IS withdrawal and this continued when IS therapy was stopped. In patients who suffered rejection (n=7) there was no increase in the CD4+CD25 high cells or FoxP3 expression. CONCLUSIONS: With the present study, the first evidence is provided that the increase of CD4+CD25 high T cells and FoxP3 transcripts is associated with operational tolerance in liver transplanted patients during IS withdrawal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AR arises from an imbalance of immune activation (IA) related to cellular and humoral antidonor responses (e.g., effector CD4+, cytotoxic CD8+ T cells, and donor-specific antibodies) over immune quiescence (IQ) suppressor countermechanisms (e.g., regulatory T cells) (27–30).”
From The Blood Proteoform Atlas: A reference map of proteoforms in human hematopoietic cells (2022) · cites this paper as [29]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 2×
“FoxP3 was mainly expressed by CD4 CD25 Treg cells, currently representing the most definitive marker for this population (13, 16), and it is a key regulatory gene for the development of these cell subsets.”
BackgroundPark, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Regulatory T cells in transplantation tolerance
Wood, K. J., & Sakaguchi, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri1027 · Cited by 1,317
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
R.Walker, M., Kasprowicz, D. J., Gersuk, V. H., Bènard, A., Van Landeghen, M., Buckner, J. H., & Ziegler, S. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19441 · Cited by 1,245
Thornton, A. M., Donovan, E. E., Piccirillo, C. A., & Shevach, E. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6519 · Cited by 560
Molecular Mechanisms Underlying FOXP3 Induction in Human T Cells
Mantel, P.-Y., Ouaked, N., Rückert, B., Karagiannidis, C., Welz, R., Blaser, K., & Schmidt-Weber, C. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3593 · Cited by 399
Multiparameter Immune Profiling of Operational Tolerance in Liver Transplantation
Martínez-Llordella, M., Puig-Pey, I., Orlando, G., Ramoni, M., Tisone, G., Rimola, A., Lerut, J., Latinne, D., Margarit, C., Bilbao, I., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01621.x · Cited by 374
WEANING OF IMMUNOSUPPRESSION IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS1
Takatsuki, M., Uemoto, S., Inomata, Y., Egawa, H., Kiuchi, T., Fujita, S., Hayashi, M., Kanematsu, T., & Tanaka, K. (2001) · Transplantation · doi:10.1097/00007890-200108150-00016 · Cited by 296
Cited by
Todo, S., Yamashita, K., Goto, R., Zaitsu, M., Nagatsu, A., Oura, T., Watanabe, M., Aoyagi, T., Suzuki, T., Shimamura, T., et al. (2016) · Hepatology · doi:10.1002/hep.28459 · Cited by 441
Sánchez–Fueyo, A., & Strom, T. B. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.059 · Cited by 236
Effector Mechanisms of Rejection
Moreau, A., Varey, E., Anegon, I., & Cuturi, M.-C. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015461 · Cited by 189
Operational tolerance after liver transplantation
Orlando, G., Soker, S., & Wood, K. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.006 · Cited by 172
The Immunological Basis of Liver Allograft Rejection
Ronca, V., Wootton, G., Milani, C., & Cain, O. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02155 · Cited by 160
The Blood Proteoform Atlas: A reference map of proteoforms in human hematopoietic cells
Melani, R. D., Gerbasi, V. R., Anderson, L. C., Sikora, J. W., Toby, T. K., Hutton, J. E., Butcher, D. S., Negrão, F., Seckler, H. S., Srzentić, K., et al. (2022) · Science · doi:10.1126/science.aaz5284 · Cited by 140
Clinical Operational Tolerance After Renal Transplantation
Orlando, G., Hematti, P., Stratta, R. J., Burke, G. W., Cocco, P. D., Pisani, F., Söker, S., & Wood, K. J. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181f3efb0 · Cited by 130
Immunosuppression minimization vs. complete drug withdrawal in liver transplantation
Londoño, M.-C., Rimola, A., O’Grady, J., & Sanchez-Fueyo, A. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.003 · Cited by 118
“, [58] 21 5.”
BackgroundUnderstanding, predicting and achieving liver transplant tolerance: from bench to bedside
Thomson, A. W., Vionnet, J., & Fueyo, A. S. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0334-4 · Cited by 113
Immunosuppression in pediatric liver transplant recipients: Unique aspects
Miloh, T., Barton, A., Wheeler, J. C., Pham, Y., Hewitt, W. R., Keegan, T., Sanchez, C., Bulut, P., & Goss, J. A. (2016) · Liver Transplantation · doi:10.1002/lt.24677 · Cited by 111
“A variety of indicators have been associated with successful withdrawal (Table 7).(51, 54, 55, 60, 65-70).”
de la Garza, R. G., Sarobe, P., Merino, J., Lasarte, J. J., D'Avola, D., Belsue, V., Delgado, J. A., Silva, L., Iñarrairaegui, M., Sangro, B., et al. (2013) · Liver Transplantation · doi:10.1002/lt.23686 · Cited by 96
“were not consistent in the 2 main studies, and the determination of some of these characteristics requires difficult or invasive procedures.(20,23) Previously, the main characteristics that differed between tolerant and nontolerant patients were observed after immunosuppression withdrawal but not at the baseline.”
ResultPreserving the B-Cell Compartment Favors Operational Tolerance in Human Renal Transplantation
Silva, H. M., Takenaka, M. C., Moraes‐Vieira, P. M., Monteiro, S. M., Hernandez, M. O., Chaara, W., Six, A., Agena, F., Sesterheim, P., Barbé‐Tuana, F. M., et al. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00281 · Cited by 103
Levitsky, J. (2011) · Liver Transplantation · doi:10.1002/lt.22265 · Cited by 86
“Blood FOXP3 transcripts in conjunction with CD4þCD25high T cells were observed in higher frequency in LT recipients who underwent successful withdrawal versus those who developed rejection.(77)”
BackgroundRegulatory T cells in solid organ transplantation
Atif, M., Conti, F., Gorochov, G., Oo, Y. H., & Miyara, M. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1099 · Cited by 86
“This is important clinically as increased FOXP3 transcripts and Treg cells have been identified in patients developing operational tolerance or reduced rejection after SOT.(39,40) Putting all this together, there is a need to delineate Treg heterogeneity using novel immunophenotyping approaches.”
BackgroundDangi, A., Sumpter, T. L., Kimura, S., Stolz, D. B., Murase, N., Raimondi, G., Vodovotz, Y., Huang, C., Thomson, A. W., & Gandhi, C. R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102460 · Cited by 77
Regulatory T-Cell Therapy in the Induction of Transplant Tolerance: The Issue of Subpopulations
Edozie, F. C., Nova‐Lamperti, E., Povoleri, G. A. M., Scottà, C., John, S., Lombardi, G., & Afzali, B. (2014) · Transplantation · doi:10.1097/tp.0000000000000243 · Cited by 82
“Although there is also data to the contrary (17), some of the divergence can be explained by the masking effect of immunosuppressive drugs, whereby Treg expansion in operationally tolerant patients manifests only after immunosuppression withdrawal has been initiated (18).”
BackgroundManzia, T. M., Angelico, R., Gazia, C., Lenci, I., Milana, M., Ademoyero, O. T., Pedini, D., Toti, L., Spada, M., Tisone, G., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i35.5356 · Cited by 76
Benítez, C., Puig-Pey, I., López, M., Martínez‐Llordella, M., Lozano, J. J., Bohne, F., Londoño, M., García-Valdecasas, J. C., Bruguera, M., Navasa, M., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03164.x · Cited by 71
“In addition, blood CD4+Foxp3+ T-cell numbers can also increase in transplant recipients by the discontinuation of calcineurin inhibitors (23,24).”
BackgroundLong-Term Hepatic Allograft Acceptance Based on CD40 Blockade by ASKP1240 in Nonhuman Primates
Oura, T., Yamashita, K., Suzuki, T., Fukumori, D., Watanabe, M., Hirokata, G., Wakayama, K., Taniguchi, M., Shimamura, T., Miura, T., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04014.x · Cited by 69
“Previous studies have demonstrated that inhibition of the CD40–CD154 signaling pathway induces regulatory T cells (Treg) (29) and that higher Treg expression in the periphery is associated with an operational tolerance in a clinical LTx setting (30).”
BackgroundMarkers of acute rejection and graft acceptance in liver transplantation
Germani, G. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i4.1061 · Cited by 61
The Evolving Role of mTOR Inhibition in Transplantation Tolerance
McMahon, G., Weir, M. R., Li, X. C., & Mandelbrot, D. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040351 · Cited by 60
Watanabe, M., Yamashita, K., Suzuki, T., Kamachi, H., Kuraya, D., Koshizuka, Y., Ogura, M., Yoshida, T., Aoyagi, T., Fukumori, D., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12330 · Cited by 61
Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation
Sagoo, P., Lombardi, G., & Lechler, R. I. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00184 · Cited by 70
The Impact of Inflammation on the Immune Responses to Transplantation: Tolerance or Rejection?
Ravindranath, M. H., Hilali, F. E., & Filippone, E. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.667834 · Cited by 58
“Monitoring the frequency of T-reg and Foxp3 mRNA expression among peripheral blood MOs in 12 hepatic allograft recipients undergoing withdrawal of immunosuppression, a progressive increase in circulating CD4+CD25+Foxp3+ T-reg and Foxp3 mRNA expression was observed (69, 70).”
BackgroundCastillo‐Rama, M., Sebagh, M., Sasatomi, E., Randhawa, P. S., Isse, K., Salgarkar, A. D., Ruppert, K. M., Humar, A., & Demetris, A. J. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12413 · Cited by 56
“The above factors might also act together to promote a ‘‘tolerogenic’’ environment (45,46), enabling a subset of patients to adapt better to the allograft compared to their counterparts with diminished IgG4, reminiscent of some cases of recurrent HCV where despite heavy infiltration of HCV-specific T cell clones, pati…”
BackgroundA Need for Biomarkers of Operational Tolerance in Liver and Kidney Transplantation
Londoño, M., Danger, R., Giral, M., Soulillou, J. P., Fueyo, A. S., & Brouard, S. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04035.x · Cited by 54
“As weaning progressed, however, both CD4+CD25high T cells and FoxP3 gene expression gradually increased in the group of operationally tolerant recipients, but not in those who developed rejection (26).”
BackgroundHot-topic debate on tolerance: Immunosuppression withdrawal
Fueyo, A. S. (2011) · Liver Transplantation · doi:10.1002/lt.22421 · Cited by 47
Approaching the Promise of Operational Tolerance in Clinical Transplantation
Bishop, G. A., Ierino, F. L., Sharland, A. F., Hall, B. M., Alexander, S. I., Sandrin, M. S., Coates, P. T., & McCaughan, G. W. (2011) · Transplantation · doi:10.1097/tp.0b013e318215e742 · Cited by 47
“There was no such increase in patients who underwent rejection (95).”
BackgroundResultChandrasekharan, D. P., Issa, F., & Wood, K. J. (2013) · Transplant International · doi:10.1111/tri.12081 · Cited by 49
“More specifically, liver patients express a high number of natural killer (NK) cell genes, whereas kidney patients express B cell genes, suggesting organ specific mechanisms of tolerance, potentially with Treg as a common end effector as highlighted by the increase in FOXP3 expression [62].”
BackgroundProgress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies
Du, X., Chang, S., Guo, W., Zhang, S., & Chen, Z. K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01326 · Cited by 50
“Relevant clinical studies have also shown that, in OT liver transplantation recipients, the proportion of Tregs in peripheral blood and liver increases, which shows a protective effect on liver allografts (118, 119).”
BackgroundMa, A., Qi, S., Song, L., Hu, Y., Dun, H., Massicotte, E., Dupuis, M., Daloze, P., & Chen, H. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.001 · Cited by 48
Biomarkers of immune tolerance in liver transplantation
Vionnet, J., & Fueyo, A. S. (2018) · Human Immunology · doi:10.1016/j.humimm.2018.02.010 · Cited by 46
“peripheral Tregs in SOT recipients [21, 32, 46].”
Immune monitoring post liver transplant
Sood, S. S. (2014) · World Journal of Transplantation · doi:10.5500/wjt.v4.i1.30 · Cited by 45
Lei, H., Reinke, P., Volk, H., Lv, Y., & Wu, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02667 · Cited by 48
Can immunosuppression be stopped after liver transplantation?
Clavien, P., Muller, X., Oliveira, M. L. D., Dutkowski, P., & Fueyo, A. S. (2017) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(16)30208-4 · Cited by 44
Cellular Mediators of Inflammation: Tregs and TH17 Cells in Gastrointestinal Diseases
Pandolfi, F., Cianci, R., Pagliari, D., Landolfi, R., & Cammarota, G. (2009) · Mediators of Inflammation · doi:10.1155/2009/132028 · Cited by 50
“This event is associated with increased levels of Tregs [86].”
BackgroundTransplant Tolerance Induction: Insights From the Liver
Dai, H., Zheng, Y., Thomson, A. W., & Rogers, N. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01044 · Cited by 45
“A progressive increase in circulating CD4CD25Foxp3 Treg and Foxp3 mRNA expression was associated with operational tolerance in liver transplant recipients (14, 116).”
BackgroundMoraes‐Vieira, P. M., Silva, H. M., Takenaka, M. C., Monteiro, S. M., Lemos, F. B. C., Saitovitch, D., Kalil, J. E., & Coelho, V. P. C. V. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.01.022 · Cited by 42
Shan, J., Guo, Y., Luo, L., Lu, J., Li, C., Zhang, C., Huang, Y., Li, F., Wu, W., Long, D., et al. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.05.006 · Cited by 41
Enrichment of Regulatory T Cells in Acutely Rejected Human Liver Allografts
Taubert, R., Pischke, S., Schlué, J., Wedemeyer, H. H., Noyan, F., Heim, A., Lehner, F., Barg‐Hock, H., Klempnauer, J. L., Olek, S., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04264.x · Cited by 42
Decreased Circulating CD4+CD25highFoxp3+ T Cells During Acute Rejection in Liver Transplant Patients
He, Q., Fan, H., Li, J. Q., & Qi, H.-X. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.03.084 · Cited by 41
Role of regulatory T cells in the promotion of transplant tolerance
Shalev, I., Selzner, N., Shyu, W., Grant, D., & Levy, G. (2012) · Liver Transplantation · doi:10.1002/lt.23458 · Cited by 40
Moraes‐Vieira, P. M., Takenaka, M. C., Silva, H. M., Monteiro, S. M., Agena, F., Lemos, F. B. C., Saitovitch, D., Kalil, J. E., & Coelho, V. P. C. V. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.08.015 · Cited by 44
“Our group and others have previously reported that the preservation of peripheral blood CD4+CD25+FOXP3+ T cells may be relevant in the process of transplantation tolerance [5-7].”
BackgroundResultBiomarkers of operational tolerance in solid organ transplantation
Heidt, S., & Wood, K. J. (2012) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2012.680019 · Cited by 38
Liu, X., Hu, Z., Pei, Y.-F., & Tao, R. (2013) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(13)60002-8 · Cited by 37
Han, J. W., Joo, D. J., Kim, J. H., Rha, M., Koh, J., Park, H. J., Lee, J. G., Kim, M. S., Kim, S. I., Shin, E., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15789 · Cited by 38
Tolerance in liver transplantation: Biomarkers and clinical relevance
Baroja‐Mazo, A., Revilla‐Nuin, B., Parrilla, P., Martínez-Alarcón, L., Ramírez, P., & Pons, J. A. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i34.7676 · Cited by 36
Self-citationRegulatory T-cell therapy in liver transplantation
Whitehouse, G. P., Hope, A. J., & Fueyo, A. S. (2017) · Transplant International · doi:10.1111/tri.12998 · Cited by 37
“ated with a transient intragraft inflammatory response that includes enrichment in Tregs [16,54,55], which clo-”
BackgroundProgress in Translational Regulatory T Cell Therapies for Type 1 Diabetes and Islet Transplantation
Marfil‐Garza, B. A., Hefler, J., de León, M. B., Pawlick, R. L., Dadheech, N., & Shapiro, A. M. J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa028 · Cited by 36
Tolerance in liver transplantation
Bishop, G. A., Bertolino, P., Bowen, D. G., & McCaughan, G. W. (2012) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2012.01.003 · Cited by 37
“of weaning, there was an increase in these markers in patients who could be successfully weaned [82].”
BackgroundClinical and Basic Research Progress on Treg-Induced Immune Tolerance in Liver Transplantation
Ni, X., Wang, Q., Gu, J., & Lu, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.535012 · Cited by 38
“5 times each time and continued to increase until the drug was completely withdrawn, but the recipients who experienced a rejection after drug withdrawal could not see this phenomenon (74).”
BackgroundJhun, J., Lee, S., Lee, S. K., Kim, H. Y., Jung, E. S., Kim, D. G., Choi, J.-W., Bae, S. H., Yoon, S. K., Chung, B. H., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00352 · Cited by 32
“who reported that Treg cells increased in tolerant patients (23), but contrast with those of García et al.”
ResultDonor reactive regulatory T cells
Feng, G., Chan, T., Wood, K. J., & Bushell, A. (2009) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32832c58f1 · Cited by 30
T-cell activation and transplantation tolerance
Priyadharshini, B., Greiner, D. L., & Brehm, M. A. (2011) · Transplantation Reviews · doi:10.1016/j.trre.2011.09.002 · Cited by 33
Strategies for Liver Transplantation Tolerance
Cvetkovski, F., Hexham, J. M., & Berglund, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052253 · Cited by 31
“Mazariegos NA 95 18 19% NA [36] Devlin/Girlanda NA 18 2 11% NA [37,38] Pons, 2003 NA 9 3 33% NA [39] Pons, 2008 490 12 5 42% 1% [40] Eason 340 18 1 6% <1% [41] Tryphonopoulos NA 104 20 19% NA [42] Tisone NA 34 8 24% NA [43] Assy NA 26 2 8% NA [44] de la Garza 138 24 15 63% 11% [45] Feng/iWITH (NCT01638559) 2909 88 33…”
BackgroundFinding the right time for weaning off immunosuppression in solid organ transplant recipients
Orlando, G. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.71 · Cited by 27
Myers, L. M., Messer, R. J., Carmody, A., & Hasenkrug, K. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900350 · Cited by 27
Revilla‐Nuin, B., de Bejar, Á., Martínez-Alarcón, L., Herrero, J. I., Martínez, C. M., Ramı́rez, P., Baroja‐Mazo, A., & Pons, J. A. (2016) · Liver Transplantation · doi:10.1002/lt.24691 · Cited by 27
“Nevertheless, previous works have pointed in this way for tolerance biomarkers such as FOXP3 expression (21) or mir142-3p (37).”
BackgroundResultSelf-citationAppenzeller‐Herzog, C., Hartleif, S., & Vionnet, J. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16585 · Cited by 29
Segundo, D. S., Fernández‐Fresnedo, G., Rodrigo, E., Ruiz, J. C., González, M., Gómez-Alamillo, C., Arias, M., & López‐Hoyos, M. (2012) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.09.083 · Cited by 26
Cell therapy in vascularized composite allotransplantation
Anggelia, M. R., Cheng, H.-Y., Lai, P., Hsieh, Y., Lin, C., & Lin, C.-H. (2022) · Biomedical Journal · doi:10.1016/j.bj.2022.01.005 · Cited by 29
Next level of immunosuppression: Drug/immune monitoring
Levitsky, J. (2011) · Liver Transplantation · doi:10.1002/lt.22385 · Cited by 25
“Blood FOXP3 in conjunction with CD4þCD25high T cells were observed at a higher frequency in LT recipients undergoing successful withdrawal versus those developing rejection.(35) More recently, gene expression profiling of tolerant liver recipients demonstrated a unique signature involving cd T cell receptors, natural…”
BackgroundJiang, X., Sun, W., Guo, D., Cui, Z.-M., Zhu, L., Lin, L., Tang, Y.-F., Wang, X., & Liang, J. (2010) · Surgery · doi:10.1016/j.surg.2010.08.012 · Cited by 25
Baroja‐Mazo, A., Revilla‐Nuin, B., de Bejar, Á., Martínez-Alarcón, L., Herrero, J. I., El‐Tayeb, A., Müller, C. E., Aparício, P., Pelegrín, P., & Pons, J. A. (2018) · American Journal of Transplantation · doi:10.1111/ajt.15023 · Cited by 26
Self-citationMonitoring the operationally tolerant liver allograft recipient
Castellaneta, A., Thomson, A. W., Nayyar, N. S., de Vera, M. E., & Mazariegos, G. V. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328334269a · Cited by 25
Fingerprints of transplant tolerance suggest opportunities for immunosuppression minimization
Sarwal, M. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.01.007 · Cited by 23
T regulatory Cell-mediated Immunotherapy for Solid Organ Transplantation: A Clinical Perspective
Khan, M. A. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00050 · Cited by 25
New Approaches to the Diagnosis of Rejection and Prediction of Tolerance in Liver Transplantation
Taner, T., Bruner, J., Emamaullee, J. A., Bonaccorsi‐Riani, E., & Zarrinpar, A. (2022) · Transplantation · doi:10.1097/tp.0000000000004160 · Cited by 26
Regulatory B cells and advances in transplantation
Li, J., Luo, Y., Wang, X., & Feng, G. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.5ru0518-199r · Cited by 24
Immune monitoring of immunosuppression withdrawal of liver transplant recipients
de la Garza, R. G., Sarobe, P., Merino, J., Lasarte, J. J., D’Avola, D., Belsúe, V., Delgado, J. A., Silva, L., Iñarrairaegui, M., Sangro, B., et al. (2015) · Transplant Immunology · doi:10.1016/j.trim.2015.07.006 · Cited by 22
Combining Adoptive Treg Transfer with Bone Marrow Transplantation for Transplantation Tolerance
Pilat, N., Granofszky, N., & Wekerle, T. (2017) · Current Transplantation Reports · doi:10.1007/s40472-017-0164-7 · Cited by 23
Schulz-Juergensen, S., Marischen, L., Wesch, D., Oberg, H., Fändrich, F., Kabelitz, D., & Burdelski, M. M. (2013) · Pediatric Transplantation · doi:10.1111/petr.12079 · Cited by 21
“In the context of immunosuppression weaning, one study examining Tregs and FoxP3 expression found different expression levels between operationally tolerant and non-tolerant patients only during the weaning process, not at baseline (17).”
BackgroundPotential of T-regulatory cells to protect xenografts
Müller, Y. D., Ehirchiou, D., Golshayan, D., Bühler, L. H., & Seebach, J. D. (2012) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283508e17 · Cited by 21
“Because Treg are found in both rejecting and tolerant animals, some authors have put forward the notion that the presence of Treg correlates with a better graft survival [58,59], whereas others postulated that the level of Foxp3 mRNA expression is predictive of the rejection risk [54,60].”
BackgroundKhan, M. A., Alanazi, F., Ahmed, H. A., Almohanna, F., Assiri, A. M., & Broering, D. C. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.11.011 · Cited by 22
Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance
Xie, Y., Wu, Y., Kang, X., Wang, J.-J., Xu, H., Ildstad, S. T., Leventhal, J. R., Yang, G., Zhang, Z., & Levitsky, J. (2017) · Transplantation · doi:10.1097/tp.0000000000001684 · Cited by 21
Angelico, R., Parente, A., & Manzia, T. M. (2017) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2017.08.07 · Cited by 22
“A total of 285 tolerant recipients have been investigated, including 20 (7%) paediatric patients (<18 years) transplanted with living donor grafts from consanguineous donors (33-39).”
BackgroundMethodInfluentialBasics and Art of Immunosuppression in Liver Transplantation
Poudel, S., Gupta, S., & Saigal, S. (2024) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2024.101345 · Cited by 28
Regulatory T Cell Therapy Following Liver Transplantation
Yu, J.-J., Liu, Z., Li, C., Wei, Q., Zheng, S., Saeb‐Parsy, K., & Xu, X. (2020) · Liver Transplantation · doi:10.1002/lt.25948 · Cited by 22
“Review ARticle | 267 who experienced LT rejection.(45) These observations suggested a potential link between Tregs and immunosuppression after LT.”
BackgroundImmunotolerance in Liver Transplantation
Mastoridis, S., Martínez‐Llordella, M., & Fueyo, A. S. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1602762 · Cited by 21
Immunological Determinants of Liver Transplant Outcomes Uncovered by the Rat Model
Wang, X., MacParland, S. A., & Perciani, C. T. (2021) · Transplantation · doi:10.1097/tp.0000000000003598 · Cited by 20
The role of regulatory T cells in liver transplantation
Beyzaei, Z., Shojazadeh, A., & Geramizadeh, B. (2021) · Transplant Immunology · doi:10.1016/j.trim.2021.101512 · Cited by 19
Wang, Y., Tian, Y., Ding, Y., Wang, J., Yan, S., Zhou, L., Xie, H., Chen, H., Li, H., Zhang, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105096 · Cited by 19
Daunting but Worthy Goal: Reducing the De Novo Cancer Incidence After Transplantation
Dantal, J., & Campone, M. (2016) · Transplantation · doi:10.1097/tp.0000000000001428 · Cited by 20
Immunosuppression Withdrawal After Liver Transplantation: What Are the Next Steps?
Mazariegos, G. V. (2011) · Transplantation · doi:10.1097/tp.0b013e31820c85a3 · Cited by 18
“The absence of donor-specific antibody (8) and the role of regulatory T cells in the graft or in peripheral blood (9) of tolerant subjects have also been proposed.”
BackgroundIdentification of tolerant recipients following liver transplantation
Fueyo, A. S. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.06.011 · Cited by 18
Segundo, D. S., Espinoza, L. G., Rodrigo, E., Irure, J., Ruiz, J. C., Fernández‐Fresnedo, G., Riesco, L., da Silva, J. B., Belmar, L., & López‐Hoyos, M. (2019) · Transplantation Direct · doi:10.1097/txd.0000000000000871 · Cited by 18
Briem‐Richter, A., Leuschner, A., Krieger, T., Grabhorn, E. F., Fischer, L., Nashan, B., Haag, F., & Ganschow, R. (2013) · Pediatric Transplantation · doi:10.1111/petr.12161 · Cited by 17
Advancing immunosuppression in liver transplantation: A narrative review
Iesari, S., Nava, F. L., Zais, I. E., Coubeau, L., Ferraresso, M., Favi, E., & Lerut, J. P. (2024) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2024.03.001 · Cited by 18
Porrett, P. M., Hashmi, S. K., & Shaked, A. A. (2014) · Clinics in Liver Disease · doi:10.1016/j.cld.2014.05.012 · Cited by 17
Immunosuppression withdrawal following liver transplantation
Whitehouse, G. P., & Fueyo, A. S. (2014) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2014.06.011 · Cited by 16
Kobayashi, S., Nagano, H., Marubashi, S., Hama, N., Tadafumi Asaoka, H. E., Takeda, Y., Tanemura, M., Doki, Y., & Mori, M. (2009) · Transplant International · doi:10.1111/j.1432-2277.2009.00991.x · Cited by 16
“Indeed, liver biopsy for the differential diagnosis of LD carries safety issues, and several clinicians have called for direct peripheral blood biomarkers [10–14].”
BackgroundTowards tolerance in liver transplantation
Toti, L., Manzia, T. M., Sensi, B., Blasi, F., Baiocchi, L., Lenci, I., Angelico, R., & Tisone, G. (2021) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2021.101770 · Cited by 20
Immunotolerance in liver transplantation: a primer for the clinician
Pérez-Escobar, J., Jiménez, J. V., Rodriguez-Aguilar, E. F., Servín-Rojas, M., Ruiz-Manríquez, J. A., Safar-Boueri, L., Carrillo-Maravilla, E., Navasa, M., & García‐Juárez, I. (2022) · Annals of Hepatology · doi:10.1016/j.aohep.2022.100760 · Cited by 16
Post-transplant liver biopsy and the immune response: lessons for the clinician
Shetty, S., Adams, D., & Hübscher, S. G. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.65 · Cited by 15
Durgam, S. S., Rosado‐Sánchez, I., Yin, D., Speck, M., Mojibian, M., Sayin, I., Hynes, G. E., Alegre, M., Levings, M. K., & Chong, A. S. (2025) · JCI Insight · doi:10.1172/jci.insight.188624 · Cited by 20
Concise Review: Immunologic Lessons From Solid Organ Transplantation for Stem Cell-Based Therapies
Loewendorf, A. I., & CSETE, M. E. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0125 · Cited by 15
Minimization of immunosuppression in adult liver transplantation: new strategies and tools
Londoño, M., López, M.-C., & Fueyo, A. S. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283402c55 · Cited by 15
Gökmen, R., & Hernández-Fuentes, M. P. (2013) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283636fd5 · Cited by 13
Mastoridis, S., Issa, F., & Wood, K. J. (2015) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000154 · Cited by 13
Advances in Liver Transplantation: where are we in the pursuit of transplantation tolerance?
Safinia, N., Vaikunthanathan, T., Lechler, R. I., Fueyo, A. S., & Lombardi, G. (2021) · European Journal of Immunology · doi:10.1002/eji.202048875 · Cited by 14
Metadata
- Authors
- Pons, J. A., Revilla-Nuin, B., Baroja-Mazo, A., Ramírez, P., Martínez-Alarcón, L., Sánchez-Bueno, F., Robles, R., Rios, A., Aparicio, P., & Parrilla, P.
- Affiliations
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
- Corresponding author
- Pons, José A.
- Venue
- Transplantation
- Published
- 2008-11-27
- Volume
- 86
- Issue
- 10
- Pages
- 1370-1378
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2075902442
- Cited by
- 179
- References
- 19
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 6 · 2023: 3 · 2022: 7 · 2021: 19 · 2020: 11 · 2019: 7 · 2018: 8 · 2017: 8 · 2016: 12 · 2015: 7 · 2014: 11 · 2013: 16 · 2012: 15
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Keywords
- Foxp3, regulatory T cells, operational tolerance, liver transplantation, immunosuppression withdrawal, cyclosporine, CD4+CD25high T cells, allograft rejection, peripheral blood mononuclear cells, Foxp3 mRNA expression
- MeSH terms
- Drug Administration Schedule, Female, Graft Survival, Humans, Immunosuppressive Agents, Liver Cirrhosis, Alcoholic, Male, Middle Aged, Retrospective Studies, RNA, Messenger, Substance Withdrawal Syndrome, Transplantation, Homologous, CD4-Positive T-Lymphocytes, Antigens, CD, Liver Transplantation, Cyclosporine, Transplantation Tolerance, T-Lymphocytes, Regulatory, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.